Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs for HIV-infected patients with discordant immunological response
NCT02290041Phase 2Completed
- Start
- Feb 2017
- Primary completion
- Jul 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CSCC_ASC in human immunodeficiency virus infection (HIV). Started Feb 2017; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02290041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290041.